Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-11-004752)

Filing Details

Accession Number:: 0001209191-11-004752
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-01-24 20:47:49
Reporting Period:: 2011-01-21

Filing Date:: 2011-01-24
Accepted Time:: 2011-01-24 20:47:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1107332	Dendreon Corp	DNDN	Pharmaceutical Preparations (2834)	223203193

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1420482	W Mark Frohlich	3005 First Avenue Seattle WA 98121	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-01-20	21,038	$0.00	204,754	No	4	A	Direct
Common Stock	Disposition	2011-01-21	2,250	$35.27	202,504	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

This restricted stock award vest as follows: 25% on the first year anniversary and 6.25% quarterly thereafter.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person